LOAMS
FATE icon

Lombard Odier Asset Management (Switzerland)’s Fate Therapeutics FATE Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-120,479
Closed -$2.7M – 364
2022
Q3 		$2.7M Sell
120,479
-8,734
-7% -$252K 0.23% 99
2022
Q2 		$3.2M Sell
129,213
-42,112
-25% -$1.16M 0.27% 91
2022
Q1 		$6.64M Sell
171,325
-100,686
-37% -$3.9M 0.52% 56
2021
Q4 		$15.9M Buy
272,011
+145,101
+114% +$8.22M 1.02% 37
2021
Q3 		$7.52M Buy
+126,910
New +$9.95M 0.47% 71

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s FATE Position: Q4 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 120,479 shares — an estimated $2.7M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in FATE in Q3 2021 and held it in 5 quarters. The position peaked at $15.9M in Q4 2021. 228 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 120,479 Fate Therapeutics shares in Q4 2022, an estimated $2.7M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Fate Therapeutics in Q3 2021 and held it in 5 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Fate Therapeutics position peaked at $15.9M in Q4 2021.
  • 228 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 14 Feb 2023.